Mc Ilrath & Eck, LLC Gsk PLC Transaction History

Mc Ilrath & Eck, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$36.52 - $41.46 $8,107 - $9,204	-222 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$32.47 - $48.83 $1,136 - $1,709	35 Added 18.72%	222 $8,000
Q3 2019 Nov 05, 2019	SELL	$40.46 - $43.52 $8,092 - $8,704	-200 Reduced 51.68%	187 $8,000
Q1 2019 May 07, 2019	BUY	$38.57 - $42.69 $8,562 - $9,477	222 Added 134.55%	387 $16,000
Q4 2018 May 07, 2019	SELL	$37.8 - $42.69 $2,646 - $2,988	-70 Reduced 29.79%	165 $6,000
Q3 2018 Nov 13, 2018	SELL	$39.75 - $42.69 $993 - $1,067	-25 Reduced 9.62%	235 $9,000
Q4 2017 Mar 19, 2018	BUY	$35.34 - $41.9 $9,188 - $10,894	260	260 $9,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $67.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Mc Ilrath & Eck, LLC, based on Form 13F filings with the SEC.

Stay updated on Mc Ilrath & Eck, LLC with notifications on news.